The Use of Direct-to-Patient Methods in Decentralized Clinical Trials in Israel
Direct-to-Patient
Clinical trials are essential for advancing medical science and developing new treatments. However, patient recruitment and retention have long been significant challenges in the clinical research process. Direct-to-patient (DtP) approaches seek to address these issues by engaging patients directly in clinical trials, outside the traditional healthcare system. In Israel, a country known for its thriving healthcare and life sciences sector, the adoption of DtP strategies in clinical trials is of particular interest.
Related Education Resources.
All ResourcesBrexit & the future landscape for clinical trial supplies in the UK and Europe
Topics: Pharma Industry, Regulatory, Supply Chain
Position Paper
Free
EAP 104: EAP Communication and Stakeholder Management
Topics: Additional Concepts, Closeout, EAP, Execution, Forecasting / Planning
Presentation
Members
COVID-19 and the Clinical Supply Chain: Mitigating Risk and Maintaining Business Continuity
Topics: COVID-19, Pharma Industry, Supply Chain
Position Paper
Free